- Home
- SMTC vs RNA Comparison
SMTC vs RNA Comparison
Compare SMTC & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTC
- RNA
- Stock Information
- Founded
- SMTC 1960
- RNA 2012
- Country
- SMTC United States
- RNA United States
- Employees
- SMTC N/A
- RNA N/A
- Industry
- SMTC Semiconductors
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- SMTC Technology
- RNA Health Care
- Exchange
- SMTC Nasdaq
- RNA Nasdaq
- Market Cap
- SMTC 4.3B
- RNA 4.0B
- IPO Year
- SMTC N/A
- RNA 2020
- Fundamental
- Price
- SMTC $64.02
- RNA $70.64
- Analyst Decision
- SMTC Strong Buy
- RNA Buy
- Analyst Count
- SMTC 15
- RNA 20
- Target Price
- SMTC $64.87
- RNA $69.26
- AVG Volume (30 Days)
- SMTC 1.5M
- RNA 10.3M
- Earning Date
- SMTC 11-24-2025
- RNA 11-10-2025
- Dividend Yield
- SMTC N/A
- RNA N/A
- EPS Growth
- SMTC N/A
- RNA N/A
- EPS
- SMTC 0.29
- RNA N/A
- Revenue
- SMTC $996,476,000.00
- RNA $20,868,000.00
- Revenue This Year
- SMTC $15.91
- RNA N/A
- Revenue Next Year
- SMTC $9.77
- RNA $108.97
- P/E Ratio
- SMTC $224.62
- RNA N/A
- Revenue Growth
- SMTC 22.22
- RNA 106.27
- 52 Week Low
- SMTC $24.05
- RNA $21.51
- 52 Week High
- SMTC $79.52
- RNA $71.09
- Technical
- Relative Strength Index (RSI)
- SMTC 42.79
- RNA 79.23
- Support Level
- SMTC $62.33
- RNA $69.67
- Resistance Level
- SMTC $75.50
- RNA $71.09
- Average True Range (ATR)
- SMTC 3.75
- RNA 0.31
- MACD
- SMTC -0.67
- RNA -0.38
- Stochastic Oscillator
- SMTC 15.17
- RNA 70.13
About SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.